Literature DB >> 29331291

Global MicroRNA Profiling in Human Bone Marrow Skeletal-Stromal or Mesenchymal-Stem Cells Identified Candidates for Bone Regeneration.

Chi-Chih Chang1, Morten T Venø2, Li Chen3, Nicholas Ditzel3, Dang Q S Le4, Philipp Dillschneider5, Moustapha Kassem6, Jørgen Kjems7.   

Abstract

Bone remodeling and regeneration are highly regulated multistep processes involving posttranscriptional regulation by microRNAs (miRNAs). Here, we performed a global profiling of differentially expressed miRNAs in bone-marrow-derived skeletal cells (BMSCs; also known as stromal or mesenchymal stem cells) during in vitro osteoblast differentiation. We functionally validated the regulatory effects of several miRNAs on osteoblast differentiation and identified 15 miRNAs, most significantly miR-222 and miR-423, as regulators of osteoblastogenesis. In addition, we tested the possible targeting of miRNAs for enhancing bone tissue regeneration. Scaffolds functionalized with miRNA nano-carriers enhanced osteoblastogenesis in 3D culture and retained this ability at least 2 weeks after storage. Additionally, anti-miR-222 enhanced in vivo ectopic bone formation through targeting the cell-cycle inhibitor CDKN1B (cyclin-dependent kinase inhibitor 1B). A number of additional miRNAs exerted additive osteoinductive effects on BMSC differentiation, suggesting that pools of miRNAs delivered locally from an implanted scaffold can provide a promising approach for enhanced bone regeneration.
Copyright © 2017 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RNAi therapeutics; bone regeneration; cell cycle regulation; mesenchymal stem cells; miRNA profiling; miRNAs; osteogenesis; scaffold; small RNA-seq; tissue engineering

Mesh:

Substances:

Year:  2017        PMID: 29331291      PMCID: PMC5835027          DOI: 10.1016/j.ymthe.2017.11.018

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  52 in total

1.  Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene.

Authors:  J F Bentzon; K Stenderup; F D Hansen; H D Schroder; B M Abdallah; T G Jensen; M Kassem
Journal:  Biochem Biophys Res Commun       Date:  2005-05-13       Impact factor: 3.575

2.  Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix.

Authors:  T A Owen; M Aronow; V Shalhoub; L M Barone; L Wilming; M S Tassinari; M B Kennedy; S Pockwinse; J B Lian; G S Stein
Journal:  J Cell Physiol       Date:  1990-06       Impact factor: 6.384

3.  MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow.

Authors:  Jie Gao; Tongtao Yang; Jianwei Han; Kang Yan; Xiuchun Qiu; Yong Zhou; Qingyu Fan; Baoan Ma
Journal:  J Cell Biochem       Date:  2011-07       Impact factor: 4.429

4.  Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation.

Authors:  Basem M Abdallah; Mandana Haack-Sørensen; Jorge S Burns; Birgitte Elsnab; Franz Jakob; Peter Hokland; Moustapha Kassem
Journal:  Biochem Biophys Res Commun       Date:  2005-01-21       Impact factor: 3.575

5.  Effects of a miR-31, Runx2, and Satb2 regulatory loop on the osteogenic differentiation of bone mesenchymal stem cells.

Authors:  Yuan Deng; Si Wu; Huifang Zhou; Xiaoping Bi; Yefei Wang; Yamin Hu; Ping Gu; Xianqun Fan
Journal:  Stem Cells Dev       Date:  2013-04-27       Impact factor: 3.272

6.  The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts.

Authors:  H Drissi; D Hushka; F Aslam; Q Nguyen; E Buffone; A Koff; A van Wijnen; J B Lian; J L Stein; G S Stein
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

7.  Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C/EBP.

Authors:  Weimin Qiu; Yuhui Hu; Tom E Andersen; Abbas Jafari; Na Li; Wei Chen; Moustapha Kassem
Journal:  J Biol Chem       Date:  2010-03-11       Impact factor: 5.157

8.  Assessment of bone formation capacity using in vivo transplantation assays: procedure and tissue analysis.

Authors:  Basem M Abdallah; Nicholas Ditzel; Moustapha Kassem
Journal:  Methods Mol Biol       Date:  2008

9.  Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation.

Authors:  Birgit Kulterer; Gerald Friedl; Anita Jandrositz; Fatima Sanchez-Cabo; Andreas Prokesch; Christine Paar; Marcel Scheideler; Reinhard Windhager; Karl-Heinz Preisegger; Zlatko Trajanoski
Journal:  BMC Genomics       Date:  2007-03-12       Impact factor: 3.969

10.  Effects of miR-146a on the osteogenesis of adipose-derived mesenchymal stem cells and bone regeneration.

Authors:  Qing Xie; Wei Wei; Jing Ruan; Yi Ding; Ai Zhuang; Xiaoping Bi; Hao Sun; Ping Gu; Zi Wang; Xianqun Fan
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

View more
  15 in total

Review 1.  MicroRNAs in the Migration of Mesenchymal Stem Cells.

Authors:  Lihong He; Huanxiang Zhang
Journal:  Stem Cell Rev Rep       Date:  2019-02       Impact factor: 5.739

Review 2.  Understanding the Transcriptomic Landscape to Drive New Innovations in Musculoskeletal Regenerative Medicine.

Authors:  Stacey M Thomas; Cheryl L Ackert-Bicknell; Michael J Zuscik; Karin A Payne
Journal:  Curr Osteoporos Rep       Date:  2022-02-14       Impact factor: 5.096

Review 3.  Advantages of Graphene Biosensors for Human Stem Cell Therapy Potency Assays.

Authors:  Roxana-Maria Amărandi; Diana F Becheru; George M Vlăsceanu; Mariana Ioniță; Jorge S Burns
Journal:  Biomed Res Int       Date:  2018-05-29       Impact factor: 3.411

4.  MiR-33a Controls hMSCS Osteoblast Commitment Modulating the Yap/Taz Expression Through EGFR Signaling Regulation.

Authors:  Viviana Costa; Valeria Carina; Lavinia Raimondi; Angela De Luca; Daniele Bellavia; Alice Conigliaro; Francesca Salamanna; Riccardo Alessandro; Milena Fini; Gianluca Giavaresi
Journal:  Cells       Date:  2019-11-22       Impact factor: 6.600

Review 5.  Mircrining the injured heart with stem cell-derived exosomes: an emerging strategy of cell-free therapy.

Authors:  Khawaja Husnain Haider; Beatrice Aramini
Journal:  Stem Cell Res Ther       Date:  2020-01-09       Impact factor: 6.832

Review 6.  Adipogenesis, Osteogenesis, and Chondrogenesis of Human Mesenchymal Stem/Stromal Cells: A Comparative Transcriptome Approach.

Authors:  Anny W Robert; Bruna H Marcon; Bruno Dallagiovanna; Patrícia Shigunov
Journal:  Front Cell Dev Biol       Date:  2020-07-08

7.  Single-cell high-content imaging parameters predict functional phenotype of cultured human bone marrow stromal stem cells.

Authors:  Justyna M Kowal; Hagen Schmal; Ulrich Halekoh; Jacob B Hjelmborg; Moustapha Kassem
Journal:  Stem Cells Transl Med       Date:  2019-11-23       Impact factor: 6.940

Review 8.  RNA-based scaffolds for bone regeneration: application and mechanisms of mRNA, miRNA and siRNA.

Authors:  Qiuping Leng; Lini Chen; Yonggang Lv
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

9.  Mechanisms of miR‑128‑3p in inhibiting osteoblast differentiation from bone marrow‑derived mesenchymal stromal cells.

Authors:  Wen Zhang; Yu Zhu; Junsheng Chen; Jiaxing Wang; Chen Yao; Chen Chen
Journal:  Mol Med Rep       Date:  2020-10-14       Impact factor: 2.952

10.  Shared Genetic and Epigenetic Mechanisms between the Osteogenic Differentiation of Dental Pulp Stem Cells and Bone Marrow Stem Cells.

Authors:  Sebastian Gaus; Hanluo Li; Simin Li; Qian Wang; Tina Kottek; Sebastian Hahnel; Xiangqiong Liu; Yupei Deng; Dirk Ziebolz; Rainer Haak; Gerhard Schmalz; Lei Liu; Vuk Savkovic; Bernd Lethaus
Journal:  Biomed Res Int       Date:  2021-02-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.